Guardion Health Sciences is a drug manufacturers - specialty & generic business based in the US. Guardion Health Sciences shares (GHSI) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $3.22 – the same closing value as a week prior. Guardion Health Sciences employs 9 staff and has a trailing 12-month revenue of around $12.2 million.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $3.22 |
|---|---|
| 52-week range | $2.53 - $7.45 |
| 50-day moving average | $3.22 |
| 200-day moving average | $7.00 |
| Wall St. target price | $40.00 |
| PE ratio | N/A |
| Dividend yield | $0 (174.67%) |
| Earnings per share (TTM) | $-4.11 |
Historical closes compared with the close of $3.22 from 2024-12-24
| 1 week (2025-04-25) | N/A |
|---|---|
| 1 month (2025-04-02) | N/A |
| 3 months (2025-02-02) | N/A |
| 6 months (2024-11-04) | 3.22 |
| 1 year (2024-05-06) | -59.75% |
|---|---|
| 2 years (2023-05-05) | 62.91% |
| 3 years (2022-05-05) | 9.51% |
| 5 years (2020-05-05) | 48.4672 |
| Revenue TTM | $12.2 million |
|---|---|
| Gross profit TTM | $5.4 million |
| Return on assets TTM | -15.53% |
| Return on equity TTM | -50.26% |
| Profit margin | 52.13% |
| Book value | $10.71 |
| Market Capitalization | $4.3 million |
TTM: trailing 12 months
Dividend payout ratio: 2.66% of net profits
Recently Guardion Health Sciences has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 200% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Guardion Health Sciences shareholders could enjoy a 200% return on their shares, in the form of dividend payments. In Guardion Health Sciences's case, that would currently equate to about $0 per share.
While Guardion Health Sciences's payout ratio might seem low, this can signify that Guardion Health Sciences is investing more in its future growth.
Guardion Health Sciences's most recent dividend payout was on 22 September 2024. The latest dividend was paid out to all shareholders who bought their shares by 23 September 2024 (the "ex-dividend date").
Guardion Health Sciences's shares were split on a 1:50 basis on 8 January 2023 . So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Guardion Health Sciences shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for Guardion Health Sciences shares which in turn could have impacted Guardion Health Sciences's share price.
Over the last 12 months, Guardion Health Sciences's shares have ranged in value from as little as $2.532 up to $7.4516. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Guardion Health Sciences's is 0.708. This would suggest that Guardion Health Sciences's shares are less volatile than average (for this exchange).
Guardion Health Sciences, Inc. , a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth. com. Guardion Health Sciences, Inc.
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
These are the stocks to buy when you don’t have much to spend.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Some of the best stock trading apps for beginners include SoFi, Robinhood, Public, Stash, Opto and more. Compare your options here.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2025 according to Finder’s comprehensive review.
Compare the 7 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .